India orders Sun Pharma to halt eye-drug output at plant
· Health · India
India ordered Sun Pharma to halt eye-care drug production at a plant after quality lapses, marking an escalation of action against the country's biggest pharmaceutical firm.
Why it matters：Tighter scrutiny of India's drug makers affects global medicine supplies, since the country is a major exporter.
Key points
- Sun Pharma ordered to halt eye-care drug output
- The action cites quality lapses
- It escalates regulatory action against India's biggest drug maker